Chongqing Lummy Pharmaceutical Co.,Ltd. Posted 54.8 Million Yuan Net Loss in First Half of 2022

Chongqing Lummy Pharmaceutical Co.,Ltd. (重庆莱美药业股份有限公司) (300006.SZ) reported a net loss of 54.8 million yuan in the first half of 2022, reversing a net profit of 31.5 million yuan for the same period in the previous year.

Meanwhile, the company posted 406.4 million yuan in revenue, down 33.6% year-on-year.

At the end of the reporting period, it had 3 billion yuan in total assets and 846.5 million yuan in total liabilities, with a liability-to-asset ratio of 28.2%.